Please Enable Images To See This
Your Financial Adviser Is Lying to You
By Dr. Steve Sjuggerud
Monday, February 26, 2018
I get so mad, I just want to scream...

I HATE IT when I get letters like the one below... because I hate it when people try to mislead our subscribers.

You see, one of our readers recently sent us a question.

And my answer is, "Your financial adviser is lying to you."

----------Recommended Links---------
'My No. 1 Stock Recommendation in 20 Years'
One of Stansberry's most successful analysts predicts that his newest stock discovery will become the first 20-bagger in Stansberry Research history over the long term. Short term, he thinks it could triple even if nothing goes right. Details here.
This could blindside you – if you're not careful...
Last year, Steve Sjuggerud helped more than 90,000 people learn how to cash in on the "Melt Up." Now, he's issued a new warning: "My most outrageous prediction is finally coming true... you may only have weeks to prepare." Click here for Steve's latest update.
---------------------------------

Here's what the subscriber wrote to us:

We just heard from one of our financial advisers that Ameriprise discovered that KraneShares is having some kind of management problems and we should be warned. Is it true and should we be cautious about our investments in several KraneShares Funds?

It is NOT true.

If you're not familiar, KraneShares provides the top exchange-traded funds (ETFs) when it comes to investing in China. I've written about two of its ETFs as ways to invest in China – the KraneShares Bosera MSCI China A Fund (KBA), and the KraneShares CSI China Internet Fund (KWEB).

The statement from the Ameriprise Financial adviser (if he really said that – I hope he didn't) borders on defamation. It's unlikely that Ameriprise is privy to information about KraneShares that nobody else knows.

More likely, Ameriprise simply doesn't want to sell the two KraneShares funds I've written about. And the financial adviser made up a reason why.

Nothing is wrong at KraneShares. And nothing is wrong with these two index funds that have a combined TWO BILLION dollars invested in them. They are not leveraged. They are two ordinary ETFs.

So what's going on here?

Barron's newspaper addressed this question two weeks ago, with a story called "The Latest Casualty in the ETF Fee War – Objective Advice."

The Barron's article explains that brokerage firms are reluctant to sell funds that they don't make much money on...

It's hardly news that money managers have been fighting for fund assets, lowering prices on index funds... Most brokers offer "no-transaction fee" ETFs. In the past, these NTF platforms were often made up of ETFs that had been chosen by independent research and data providers, such as Morningstar... Now, the funds on these NTF platforms are largely a function of ETF providers paying to be there.

Barron's doesn't mention Ameriprise in particular. This is just a relatively new industry-wide issue for all brokerage firms. If the brokerage firm doesn't make money by selling that ETF, then it doesn't "approve" selling it.

Here's the way these relatively new conversations go:

Customer: "Hi, I would like to buy an index fund ETF with the symbol XYZ."

Broker: "I'm sorry, we can't buy that fund for you."

Customer: "What? But, why? It doesn't seem any riskier than any other ETF."

Broker: "Our company has determined that the fund is unsuitable. You can't buy it."

Saying it's "unsuitable" is bad enough. That's not telling the customer the whole story of why the firm won't sell the fund. (Besides, it raises the question – "unsuitable for whom?")

But warning the customer that there are "management problems" – when there aren't management problems – is far worse.

Some firms have found other, more honest solutions...

Fidelity, for example, doesn't make much money on Vanguard funds. Instead of dropping Vanguard funds and making up excuses, early this year, Fidelity instituted a 0.05% fee on Vanguard funds held in 401(k) plans.

So what should you do if a brokerage firm comes back to you and tells you a simple, ordinary index fund is "unsuitable"?

I would suggest checking with other brokerage firms to see if they can buy it for you.

It might be time to change brokers...

Good investing,

Steve
Further Reading:

"Never, ever allow a broker to be in charge of the conversation," Mark Ford says. "You're the boss. He should listen to you." Check out his classic essay about why you shouldn't be "loyal" to your broker right here.
 
"Your broker might scoff at this..." Dave Eifrig writes. If you deal with a broker or financial adviser – and if you use stops to protect your investments – make sure you're not falling prey to this mistake. Read more here.
  Print


NEW HIGHS OF NOTE LAST WEEK
 
U.S. Steel (X)... steel
Steel Dynamics (STLD)... steel
Raytheon (RTN)... "offense" contractor
Palo Alto Networks (PANW)... cybersecurity
Proofpoint (PFPT)... cybersecurity
Interactive Brokers (IBKR)... online brokerage
Moody's (MCO)... credit ratings
M&T Bank (MTB)... regional bank
PNC Financial Services (PNC)... regional bank
SunTrust Banks (STI)... regional bank
Green Dot (GDOT)... prepaid debit cards
Intuit (INTU)... TurboTax, QuickBooks
Salesforce.com (CRM)... software for businesses
Workday (WDAY)... cloud software
Adobe Systems (ADBE)... software
Nvidia (NVDA)... chipmaker
GoDaddy (GDDY)... Internet domain names
Shutterfly (SFLY)... digital photos, prints
Amazon (AMZN)... "FANG" stock
Shopify (SHOP)... e-commerce powerhouse
Grubhub (GRUB)... on-demand food delivery
Bloomin' Brands (BLMN)... casual-dining restaurants
Dine Brands Global (DIN)... IHOP, Applebee's
Domino's Pizza (DPZ)... pizza
Live Nation Entertainment (LYV)... concerts
Madison Square Garden (MSG)... concerts and sports
Coty (COTY)... cosmetics
Estée Lauder (EL)... cosmetics
Weight Watchers (WTW)... weight-loss help

NEW LOWS OF NOTE LAST WEEK
 
Campbell Soup (CPB)... soups, sauces, baked goods
Kraft Heinz (KHC)... ketchup, cheese, and more
Apache (APA)... oil and gas
Cemex (CX)... cement
Nielsen (NLSN)... data and analytics

Increase your profit potential without blowing up your portfolio...
 
"Don't put all of your eggs in one basket" is the basic idea behind asset allocation. But it gets much deeper than that...
 
 
Are You a
New Subscriber?

If you have recently subscribed to a Stansberry Research publication and are unsure about why you are receiving the DailyWealth (or any of our other free e-letters), click here for a full explanation...
 
 
Advertisement

Maryland farmer pens controversial letter on the U.S. wealth gap. Reviewer says: "I disapprove of this... and the author can burn in hell." Click here to learn more.
 
recent articles

Three Steps to Survive the Next 'Black Monday' Crash
By Chris Mayer
Friday, February 23, 2018
 
When the next crash comes, they'll blame the machines. And they'll be wrong – again...
 
Two Reasons Oil Prices Are Headed Lower
By Brett Eversole
Thursday, February 22, 2018
 
The plan was to cut production by 1.2 million barrels of oil per day through 2018. And the cartel is keeping its promise so far...
 
The Return of Volatility
By Ben Morris
Wednesday, February 21, 2018
 
A funny thing happened during the late 1990s dot-com mania... It had never happened before. And it hasn't happened since. But it may be starting to happen again...
 
Are You Contrarian Enough for This Trade?
By Dr. Steve Sjuggerud
Tuesday, February 20, 2018
 
Eleven billion dollars... That's how much money two major funds lost in combined market value over the last few weeks.
 
Porter's Latest Prediction Just Came True
By Justin Brill
Saturday, February 17, 2018
 
Last summer, Stansberry Research founder Porter Stansberry warned that a significant stock market correction was now certain for the first time in years. Surely, Porter is even more bearish now? Not exactly...
 

Home | About Us | Resources | Archive | Free Reports | Privacy Policy
To unsubscribe from DailyWealth and any associated external offers, click here.

Copyright 2018 Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC., 1125 N Charles St, Baltimore, MD 21201

LEGAL DISCLAIMER: This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies) employees and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday – Friday between 9:00 AM and 5:00 PM Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles St, Baltimore, MD 21201, USA.

If you wish to contact us, please do not reply to this message but instead go to info@stansberrycustomerservice.com. Replies to this message will not be read or responded to. The law prohibits us from giving individual and personal investment advice. We are unable to respond to emails and phone calls requesting that type of information.